Target intelligence / Profile preview

Intestinal epithelial metabolic pathways

Molecular classification
Other
01

Overview

Intestinal epithelial metabolic pathways encompass the complex network of biochemical reactions within the gut lining that sustain cellular energy and systemic homeostasis (Rath et al., 2018, PMID: 30115606). These pathways are critical for nutrient absorption, the metabolism of amino acids like glutamine—the primary fuel for enterocytes—and the detoxification of drugs and toxins via the cytochrome P450 system (Zhu et al., 2021, PMID: 34153879). In the context of disease, metabolic reprogramming in enterocytes is a key feature of inflammatory bowel disease (IBD), where a shift from oxidative phosphorylation to glycolysis can compromise barrier integrity and promote inflammation (Aden et al., 2019, PMID: 31611050). While not a single therapeutic target, these pathways are modulated by various pharmacological agents to improve gut health or manage metabolic disorders. For instance, targeting specific transporters or enzymes within these pathways is a common strategy in treating malabsorption and type 2 diabetes (Takiishi et al., 2017, PMID: 28345167). Because this term describes a collection of pathways rather than a specific protein or receptor, it is classified as a broad biological system rather than a discrete therapeutic target.

Other names
Intestinal metabolismEnterocyte metabolic pathwaysGut epithelial metabolismIntestinal mucosal metabolism
02

Mechanism of action

Not applicable; this term refers to a broad set of biochemical processes rather than a single molecular target.

03

Biological functions

Nutrient absorption and processingEnergy homeostasisIntestinal barrier maintenanceXenobiotic metabolismImmune signaling modulation
04

Disease associations

Inflammatory bowel diseaseCeliac diseaseColorectal cancerMetabolic syndromeShort bowel syndrome
05

Safety considerations

Systemic metabolic disruptionNutrient malabsorptionImpaired intestinal barrier function (leaky gut)Alteration of drug pharmacokinetics
06

Biomarkers

Citrulline (marker of enterocyte mass)Intestinal fatty acid-binding protein (I-FABP)Fecal calprotectinShort-chain fatty acids (SCFAs)

Beyond the preview

Go deeper on Intestinal epithelial metabolic pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial metabolic pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call